Adenoviral vector-mediated gene therapy in the mouse lung: No role of Fas-Fas ligand interactions for elimination of transgene expression in bronchioepithelial cells

Human Gene Therapy

Volumn 10, Issue 17, 1999, Pages 2839-2846

  Chirmule, Narendra ^a   Moffett, Jennifer ^a   Dhagat, Parag ^a   Tazelaar, John ^a   Wilson, James M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; GENE PRODUCT; VIRUS PROTEIN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ARTICLE; BRONCHUS MUCOSA; CYTOTOXIC T LYMPHOCYTE; EPITHELIUM CELL; GENE EXPRESSION; GENE LOSS; GENE THERAPY; IMMUNE RESPONSE; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PROTEIN PROTEIN INTERACTION; TRANSGENE;

ADENOVIRIDAE; ANIMALS; ANTIGENS, CD95; BRONCHI; EPITHELIAL CELLS; FAS LIGAND PROTEIN; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; LUNG; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES, CYTOTOXIC; TRANSGENES;

ADENOVIRIDAE; ANIMALIA; BRONCHUS;

EID: 0033589754     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950016564     Document Type: Article

References (27)

1. BONOFOCO, E., STUART, P.M., BRUNNER, T., LIN, T., GRIFFITH, T.S., HENKART, P.A., FERGUSON, T.A., and GREEN, D.R. (1999). Inducible non-lymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells. Immunity 9, 711-720.
2. BROMBERG, J.S., DEBRUYNE, L.A., and QUIN, L. (1998). Interactions between the immune system and gene therapy vectors: Bidirectional regulation of response and expression. Adv. Immunol. 69, 353-409.
3. CHIRMULE, N., HUGHES, J.V., GAO, G.P., RAPER, S.E., and WILSON, J.M. (1998). Role of E4 in eliciting CD4 T-cell and B-cell responses to adenovirus vectors delivered to murine and nonhuman primate lungs. J. Virol. 72, 6138-6145.
4. CHIRMULE, N., MOSCIONI, A.D., QIAN, Y., QIAN, R., CHEN, Y., and WILSON, J.M. (1999). Fas-FasL interactions play a major role in effector functions of CTL following adenovirus vector-mediated gene transfer. Hum. Gene Ther. 72, 6138-6145.
5. CRYSTAL, R. (1995). Transfer of genes to humans: Early lessons and obstacles to success. Science 270, 404-410.
6. ELKON, K.B., LIU, C.-C., GALL, J.G., TREVEJO, J., MARINO, M.W., ABRAHAMSEN, K.A., SONG, X., ZHOU, J-L., OLD, L.J., CRYSTAL, R.G., and FALCK-PEDERSEN, E. (1997). Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenovirus vectors. Proc. Natl. Acad. Sci. U.S.A. 94, 9814-9819.
7. GEORGE, J.F., SWEENEY, S.D., KIRKLIN, J.K., SIMPSON, E.M., GOLDSTEIN, D.R., and THOMAS, J.M. (1998). An essential role for Fas ligand in transplantation tolerance induced by donor bone marrow. Nature Med. 4, 333-335.
8. GIORDANO, C., STASSI, G., DE MARIA, R., TODARO, M., RICHIUSA, P., PAPOFF, G., RUBERTI, G., BAGNASCO, M., TESTI, R., and GALLUZZO, A. (1997). Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275, 960-963.
9. GREEN, D.R., and WARE, C.F. (1997). Fas-ligand: Privilege and peril. Proc. Natl. Acad. Sci. U.S.A. 94, 5986-5990.
10. GRIFFITH, T.S., and FERGUSON, T.A. (1997). The role of FasL-induced apoptosis in immune privilege. Immunol. Today 18, 240-244.
11. HAMANN. K.J., DORSCHEID, D.R., KO, F.D., CONFORTI, A.E., SPERLING, A.I., RABE, K.F., and WHITE, S.R. (1998). Expression of Fas (CD95) and FasL (CD95L) in human airway epithelium. Am. J. Respir. Cell Mol. Biol. 19, 537-542.
12. KAGI, D., LEDERMANN, B., BURKI, K., ZINKERNAGEL, R.M., and HENGARTNER, H. (1996). Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 14, 207-232.
13. KONDO, T., SUDA, T., FUKUYAMA, H., ADACHI, M., and NAGATA, S. (1997). Essential roles of the Fas ligand in the development of hepatitis. Nature Med. 3, 409-413.
14. LIN, T., BRUNNER, T., TIETZ, B., MADSEN, J., BONFOCO, E., REAVES, M., HUFLEJT, M., and GREEN, D.R. (1998). Fas ligand-mediated killing by intestinal intraepithelial lymphocytes. J. Clin. Invest. 101, 570-577.
15. NAGATA, S. (1997). Apoptosis by death factor. Cell 88, 355-365.
16. NAGATA, S., and GOLDSTEIN, P. (1995). The Fas death factor. Science 267, 1449-1456.
17. SCHOWALTER, D.B., TUBE, J.C., LIU, M., WILSON, C.B., and KAY, M.A. (1997). Heterologous expression of adenovirus E3-gp19K in an E1a-deleted adenovirus vector inhibits MHC I expression in vitro, but does not prolong transgene expression in vivo. Gene Ther. 4, 351-360.
18. SMYTH, M.J., and TRAPANI, J.A. (1998). The relative role of lymphocyte granule exocytosis versus death receptor-mediated cytotoxicity in viral pathophysiology. J. Virol. 72, 1-9.
19. TAKAHASHI, T., MASATO, T., BRANNAN, C.I., JENKINS, N.A., COPELAND, N.G., SUDA, T., and NAGATA, S. (1994). Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969-976.
20. TRIPATHY, S.K., GOLDWASSER, B.H., and LEIDEN, J.M. (1996). Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nature Med. 22, 545-550.
21. WATANABE-FUKUNAGA, R., BRANNAN, C.I., COPELAND, N.G., JENKINS, N.A., and NAGATA, S. (1992). Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature (London) 356, 314-317.
22. YANG, Y., ERTL, H.C.J., and WILSON, J.M. (1994). MHC class I restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. J. Immun. 1, 433-442.
23. YANG, Y., LI, Q., ERTH, H.C., and WILSON, J.M. (1995a). Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenovirus. J. Virol. 69, 2004-2015.
24. YANG, Y., XIANG, Z., ERTL, H.C.J., and WILSON, J.M. (1995b). Upregulation of class I MHC antigens by Interferon-γ is necessary for the T cell-mediated elimination of recombinant adenovirus infected hepatocytes in vivo. Proc. Natl. Acad. Sci. U.S.A. 92, 7257-7261.
25. YANG, Y., JOOSS, K.U., SU, Q., ERTL, H.C., and WILSON, J.M. (1996a). Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther. 3, 137-144.
26. YANG, Y., SU, Q., and WILSON, J.M. (1996b). Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs. J. Virol. 70, 7209-7212.
27. ZHANG, H., YANG, Y., HORTON, J.L., SAMOILOVA, E.B., JUDGE, T.A., TURKA, L.A., WILSON, J.M., and CHEN, Y. (1997). Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer. J. Clin. Invest. 100, 1951-1957.